Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Dutasteride is a dual inhibitor of 5α-reductase types I and II (Kis = 6 and 7 nM, respectively).1,2,3 Its inhibition is time-dependent inhibitor with apparent Ki values of 17 and 4.3 nM at 10- and 30-minute reaction times, respectively.1 Dutasteride decreases prostate weight in a rat model of benign prostatic hypertrophy induced by testosterone after castration when administered daily for 28 days at doses of 0.045 mg/kg as a solution or 0.756 mg/kg in subcutaneous microspheres.4 It also decreases prostate weight in large probasin-large T antigen mice, a transgenic model of prostate cancer.5 Formulations containing dutasteride have been used in the treatment of benign prostatic hyperplasia.
WARNING This product is not for human or veterinary use.
1. Pharmacogenetic analysis of human steroid 5α reductase type II: Comparison of finasteride and dutasteride. J. Mol. Endocrinol. 34(3), 617-623 (2005).
2. Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR. J. Pharmacol. Exp. Ther. 282(3), 1496-1502 (1997).
3. 17β-
4. Controlled release of dutasteride from biodegradable microspheres: In vitro and in vivo studies. PLoS One 9(12), e114835 (2014).
5. Effects of dutasteride on prostate growth in the large probasin-